zidovudine has been researched along with Cardiac Hypertrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, T; Chin, MT; Dai, DF; Dorn, GW; Johnson, SC; Kang, YJ; Marcinek, DJ; Nieves-CintrĂ³n, M; Prolla, TA; Rabinovitch, PS; Santana, LF; Villarin, JJ | 1 |
Colan, SD; Hale, AR; Lipshultz, SE; McIntosh, K; Orav, EJ; Sanders, SP | 1 |
2 other study(ies) available for zidovudine and Cardiac Hypertrophy
Article | Year |
---|---|
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure.
Topics: Angiotensin II; Animals; Cardiomegaly; Catalase; DNA Damage; DNA, Mitochondrial; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Mice; Mice, Transgenic; Mitochondria, Heart; Models, Animal; Myocytes, Cardiac; Oxidative Stress; Reactive Oxygen Species; Reverse Transcriptase Inhibitors; Zidovudine | 2011 |
Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine.
Topics: Acquired Immunodeficiency Syndrome; Cardiomegaly; Child; Child, Preschool; Dilatation, Pathologic; Echocardiography; Female; Follow-Up Studies; Heart; Heart Ventricles; HIV Infections; Humans; Infant; Male; Myocardium; Zidovudine | 1992 |